Your Unread Messages
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Casopitant improves the quality of life in patients receiving highly emetogenic chemotherapy
Supportive Care in Cancer, 11/06/09
Gridelli C et al. – The addition of casopitant to ondansetron and dexamethasone in patients receiving HEC was significantly more effective in reducing the impact of nausea and vomiting on all daily life activities as assessed by the FLIE compared with ondansetron/dexamethasone dual therapy.
Methods- Multicenter, double-blind, randomized, placebo-controlled, add-on trial (N?=?810)
- Patients randomized to intravenous (IV) ondansetron/dexamethasone alone (control) or in combination with either single 150-mg oral dose of casopitant or 3-day IV/oral casopitant
- Quality of life assessed as impact of nausea and vomiting on daily life using Functional Living Index Emesis (FLIE) questionnaire
- Patients completed FLIE questionnaire at baseline prior to receiving chemotherapy and after completion of first cycle of HEC
- Patients in single oral dose and 3-day IV/oral casopitant groups scored higher mean total FLIE scores than patients in control group , indicating that casopitant patients experienced less impact from nausea and vomiting on daily life
- Overall absolute difference in proportion of patients reporting CINV with no impact on daily life between single oral casopitant group and control group was 13%
- Difference between 3-day IV/oral casopitant group and control group was 14%
Today in Hematology/Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Approach to Thrombocytopenia in Older Adults
Geriatrics & Aging, 11/10/09
Update on oral lichen planus
Expert Review of Dermatology, 10/14/09
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
Thyroid, 10/30/09
Sponsor
Article Search
Sponsor
Sponsor


See All



